Results 131 to 140 of about 449,349 (233)

Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents. [PDF]

Pharmaceuticals (Basel)
Hennrich U, Wagner L, Taş H, Kovacs L, Benešová-Schäfer M.   +4 more
europepmc   +1 more source

CAIX-targeted PET imaging agents based on acetazolamide small molecule for clear cell renal cell carcinoma. [PDF]

Am J Nucl Med Mol Imaging
Li C, Hu Q, Liang SH.
europepmc   +1 more source

Synthesis, uptake mechanism characterization and biological evaluation of (18)F labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents.

Nuclear Medicine and Biology, 2011
Limin Wang, Wenchao Qu, B. Lieberman, K. Plössl, H. Kung   +4 more
semanticscholar   +1 more source

Rapid, palladium-based synthesis of 18F-labeled PET imaging agents [PDF]

Science-Business eXchange, 2011
openaire   +1 more source

PSMA-targeted PET Imaging Agent Fluorine F 18 CTT-1057 [PDF]

, 2020
openaire   +1 more source

Peptidomimetic GHS-R1a Agonists as PET Imaging Agents for Prostate Cancer

, 2014
Contemporary diagnostic techniques for prostate cancer (PCa) have a limited ability to distinguish between benign and malignant disease. The ghrelin receptor has a differential expression in normal, benign and cancerous prostatic tissue. Targeting this receptor with 18F-radiolabelled peptidomimetics would enable differentiation between these disease ...
openaire   +1 more source

Synthesis and Biological Evaluation of Fluorine-18 and Deuterium Labeled l-Fluoroalanines as Positron Emission Tomography Imaging Agents for Cancer Detection. [PDF]

J Med Chem
Li K, Gilberti AL, Marden JA, Akula HK, Pollard AC, Guo S, Hu B, Tonge PJ, Qu W.   +8 more
europepmc   +1 more source

Copper-mediated late-stage radiofluorination: five years of impact on preclinical and clinical PET imaging

Clinical and translational imaging, 2020
Jay S Wright, Tanpreet Kaur, Sean M. Preshlock, Sean S. Tanzey, Wade P. Winton, Liam S. Sharninghausen, Nicholas Wiesner, Allen F. Brooks, M. Sanford, P. Scott   +9 more
semanticscholar   +1 more source

Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer's disease with PET imaging agents ¹⁸F-flutemetamol and ¹⁸F-florbetaben. [PDF]

BMC Neurosci, 2018
Son HJ, Jeong YJ, Yoon HJ, Lee SY, Choi GE, Park JA, Kim MH, Lee KC, Lee YJ, Kim MK, Cho K, Kang DY.   +11 more
europepmc   +1 more source

New 18F-Radiochemistry and Application for Development of PET Imaging Agents.

New 18F-Radiochemistry and Application for Development of PET Imaging Agents.
2nd Research Coordination Meeting on Development of 18F-labelled Radiopharmaceuticals (beyond [18F]FDG) for Use in Oncology and ...
openaire